• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺神经内分泌肿瘤的临床病理及免疫组化研究——单中心经验

Clinicopathological and immunohistochemical study of pulmonary neuroendocrine tumors - A single-institute experience.

作者信息

Pasala Uma Jyothi Swaroopa, Hui Monalisa, Uppin Shantveer G, Kumar N Narendra, Bhaskar K, Paramjyothi G K

机构信息

Department of Pathology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.

Department of Pulmonology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.

出版信息

Lung India. 2021 Mar-Apr;38(2):134-138. doi: 10.4103/lungindia.lungindia_482_19.

DOI:10.4103/lungindia.lungindia_482_19
PMID:33687006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8098896/
Abstract

INTRODUCTION

Pulmonary neuroendocrine tumors (NETs) comprise a spectrum of tumors ranging from indolent to highly aggressive neoplasm. This study aims to study the clinicopathological and immunohistochemical features of NETs and assess the sensitivity of various IHC markers.

MATERIALS AND METHODS

All consecutive cases of pulmonary NETs diagnosed from January 2016 to June 2019 were analyzed retrospectively. The routine hematoxylin- and eosin-stained sections along with immunohistochemistry (IHC) slides were reviewed. IHC was done using a panel of markers which included synaptophysin, chromogranin, CD56, thyroid transcription factor-1 (TTF-1), p-40, napsin-A, and ki67.

RESULTS

Of total number of 53 patients, diagnosis was made on biopsy in 40 patients and resection specimen in 13 patients. Small cell lung carcinoma was the most common (31 cases), followed by 16 cases of typical carcinoid, 5 cases of atypical carcinoid, and 1 case of combined SCLC. Both synaptophysin and chromogranin were positive in all the cases of typical carcinoid. Synaptophysin had better sensitivity than chromogranin in atypical carcinoid and small cell carcinoma. CD56 was positive in 8 out of 9 cases done. TTF-1 was negative in all the cases of typical carcinoid. The sensitivity of TTF-1 in small cell carcinoma was 85.19%. The mean Ki67 labeling index was 1.4%, 6.6%, and 65.6% in typical, atypical carcinoid, and small cell carcinomas, respectively.

CONCLUSION

Synaptophysin was more sensitive than chromogranin, especially in atypical carcinoid and small cell carcinoma. TTF-1 along with high Ki67 differentiates small cell carcinoma from carcinoid.

摘要

引言

肺神经内分泌肿瘤(NETs)包括一系列从惰性到高度侵袭性的肿瘤。本研究旨在探讨NETs的临床病理和免疫组化特征,并评估各种免疫组化标志物的敏感性。

材料与方法

回顾性分析2016年1月至2019年6月诊断的所有连续性肺NETs病例。复习常规苏木精-伊红染色切片及免疫组化(IHC)玻片。免疫组化使用一组标志物,包括突触素、嗜铬粒蛋白、CD56、甲状腺转录因子-1(TTF-1)、p-40、 napsin-A和ki67。

结果

53例患者中,40例通过活检确诊,13例通过切除标本确诊。小细胞肺癌最为常见(31例),其次是16例典型类癌、5例非典型类癌和1例混合性小细胞肺癌。所有典型类癌病例中突触素和嗜铬粒蛋白均为阳性。在非典型类癌和小细胞癌中,突触素的敏感性高于嗜铬粒蛋白。9例检测病例中有8例CD56呈阳性。所有典型类癌病例中TTF-1均为阴性。TTF-1在小细胞癌中的敏感性为85.19%。典型类癌、非典型类癌和小细胞癌的平均Ki67标记指数分别为1.4%、6.6%和65.6%。

结论

突触素比嗜铬粒蛋白更敏感,尤其是在非典型类癌和小细胞癌中。TTF-1与高Ki67有助于将小细胞癌与类癌区分开来。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f76/8098896/1ab899539ab2/LI-38-134-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f76/8098896/82c384758702/LI-38-134-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f76/8098896/47442fb8550c/LI-38-134-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f76/8098896/1ab899539ab2/LI-38-134-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f76/8098896/82c384758702/LI-38-134-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f76/8098896/47442fb8550c/LI-38-134-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f76/8098896/1ab899539ab2/LI-38-134-g003.jpg

相似文献

1
Clinicopathological and immunohistochemical study of pulmonary neuroendocrine tumors - A single-institute experience.肺神经内分泌肿瘤的临床病理及免疫组化研究——单中心经验
Lung India. 2021 Mar-Apr;38(2):134-138. doi: 10.4103/lungindia.lungindia_482_19.
2
Expression and Clinicopathological Significance of SOX11 in Small-Cell Lung Cancer.SOX11 在小细胞肺癌中的表达及临床病理意义。
Biomed Res Int. 2022 Mar 30;2022:1707914. doi: 10.1155/2022/1707914. eCollection 2022.
3
Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections.胰岛素瘤相关蛋白 1(INSM1)是原发性肺肿瘤神经内分泌分化的一个敏感且高度特异的标志物:345 例病例的免疫组化研究,包括 292 例全组织切片。
Mod Pathol. 2019 Jan;32(1):100-109. doi: 10.1038/s41379-018-0122-7. Epub 2018 Aug 28.
4
Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses.肺神经内分泌肿瘤 90 例临床病理特征、免疫表型、术前活检及冷冻切片诊断研究
J Surg Oncol. 2014 Mar;109(3):280-6. doi: 10.1002/jso.23497. Epub 2013 Dec 3.
5
Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 cases.胸腺神经内分泌肿瘤(副神经节瘤和类癌肿瘤):46例病例的比较免疫组织化学研究
Hum Pathol. 2014 Dec;45(12):2463-70. doi: 10.1016/j.humpath.2014.08.013. Epub 2014 Sep 6.
6
Clinicopathological characteristics of thyroid transcription factor 1-negative small cell lung cancers.甲状腺转录因子 1 阴性小细胞肺癌的临床病理特征。
Hum Pathol. 2018 Sep;79:127-134. doi: 10.1016/j.humpath.2018.05.009. Epub 2018 May 19.
7
Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.神经内分泌标记物在非神经内分泌型子宫内膜癌中的表达。
Pathology. 2019 Jun;51(4):369-374. doi: 10.1016/j.pathol.2019.02.003. Epub 2019 Apr 27.
8
Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma.39例膀胱神经内分泌癌的临床病理特征及预后因素分析
Anticancer Res. 2017 Aug;37(8):4529-4537. doi: 10.21873/anticanres.11850.
9
Co-expression of TTF-1 and neuroendocrine markers in the human fetal lung and pulmonary neuroendocrine tumors.TTF-1与神经内分泌标志物在人胎儿肺及肺神经内分泌肿瘤中的共表达。
Acta Histochem. 2015 May-Jun;117(4-5):451-9. doi: 10.1016/j.acthis.2015.02.002. Epub 2015 Feb 24.
10
Clinical significances of TTF-1, neuroendocrine (chromogranin, synaptophysin, CD56), and keratin (pancytokeratin, CK7, CK5/6) marker immunostaining in small cell lung cancer.TTF-1、神经内分泌(嗜铬粒蛋白、突触素、CD56)和角蛋白(全细胞角蛋白、CK7、CK5/6)标志物免疫染色在小细胞肺癌中的临床意义
Clin Transl Oncol. 2025 Mar;27(3):1075-1083. doi: 10.1007/s12094-024-03683-2. Epub 2024 Aug 30.

引用本文的文献

1
Application of Artificial Intelligence in Neuroendocrine Lung Cancer Diagnosis and Treatment: A Systematic Review.人工智能在神经内分泌肺癌诊断与治疗中的应用:一项系统综述
Cureus. 2024 May 24;16(5):e61012. doi: 10.7759/cureus.61012. eCollection 2024 May.
2
Single-cell RNA sequencing data imputation using bi-level feature propagation.基于双层特征传播的单细胞 RNA 测序数据插补。
Brief Bioinform. 2024 Mar 27;25(3). doi: 10.1093/bib/bbae209.
3
Angioside: The role of Angiogenesis and Hypoxia in Lung Neuroendocrine Tumours According to Primary Tumour Location in Left or Right Parenchyma.

本文引用的文献

1
The utility of Ki-67 as a prognostic biomarker in pulmonary neuroendocrine tumours: protocol for a systematic review and meta-analysis.Ki-67作为肺神经内分泌肿瘤预后生物标志物的效用:系统评价和荟萃分析方案
BMJ Open. 2019 Aug 24;9(8):e031531. doi: 10.1136/bmjopen-2019-031531.
2
Clinicopathological Profiling of Lung Carcinoids with a Ki67 Index > 20.Ki67 指数>20%的肺类癌的临床病理特征分析。
Neuroendocrinology. 2019;108(2):109-120. doi: 10.1159/000495806. Epub 2018 Nov 28.
3
Histological transformation of adenocarcinoma to small cell carcinoma lung as a rare mechanism of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors: Report of a case with review of literature.
血管苷:根据原发性肿瘤位于左肺或右肺实质,血管生成和缺氧在肺神经内分泌肿瘤中的作用
J Clin Med. 2022 Oct 9;11(19):5958. doi: 10.3390/jcm11195958.
腺癌组织学转化为小细胞肺癌作为一种罕见的表皮生长因子受体酪氨酸激酶抑制剂耐药机制:1例报告并文献复习
Lung India. 2018 Mar-Apr;35(2):160-163. doi: 10.4103/lungindia.lungindia_347_17.
4
Lung neuroendocrine tumors: pathological characteristics.肺神经内分泌肿瘤:病理特征
J Thorac Dis. 2017 Nov;9(Suppl 15):S1442-S1447. doi: 10.21037/jtd.2017.01.59.
5
Classification of pulmonary neuroendocrine tumors: new insights.肺神经内分泌肿瘤的分类:新见解
Transl Lung Cancer Res. 2017 Oct;6(5):513-529. doi: 10.21037/tlcr.2017.09.04.
6
Neuroendocrine Tumors of the Lung: Current Challenges and Advances in the Diagnosis and Management of Well-Differentiated Disease.肺神经内分泌肿瘤:分化良好疾病的诊断和治疗的当前挑战和进展。
J Thorac Oncol. 2017 Mar;12(3):425-436. doi: 10.1016/j.jtho.2016.11.2222. Epub 2016 Nov 24.
7
Grading lung neuroendocrine tumors: Controversies in search of a solution.肺神经内分泌肿瘤的分级:寻求解决方案中的争议
Histol Histopathol. 2017 Mar;32(3):223-241. doi: 10.14670/HH-11-822. Epub 2016 Sep 15.
8
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.《2015年世界卫生组织肺、胸膜、胸腺和心脏肿瘤分类》简介
J Thorac Oncol. 2015 Sep;10(9):1240-1242. doi: 10.1097/JTO.0000000000000663.
9
Unraveling tumor grading and genomic landscape in lung neuroendocrine tumors.解析肺神经内分泌肿瘤的肿瘤分级和基因组图谱。
Endocr Pathol. 2014 Jun;25(2):151-64. doi: 10.1007/s12022-014-9320-0.
10
Grading the neuroendocrine tumors of the lung: an evidence-based proposal.肺神经内分泌肿瘤分级:循证建议。
Endocr Relat Cancer. 2013 Dec 16;21(1):1-16. doi: 10.1530/ERC-13-0246. Print 2014 Feb.